We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPLI
251
People Inc
PPLI
$3.2B
$1.29M 0.04%
+33,523
New +$1.39M
AAT
252
American Assets Trust
AAT
$1.38B
$1.28M 0.04%
57,328
+9,228
+19% +$198K
AGEN
253
Agenus
AGEN
$312M
$1.26M 0.04%
+75,189
New +$908K
KRC icon
254
Kilroy Realty
KRC
$4.34B
$1.26M 0.04%
40,382
-8,343
-17% -$277K
IFRX icon
255
InflaRx
IFRX
$253M
$1.26M 0.04%
721,768
+339,359
+89% +$498K
KLAC icon
256
KLA
KLAC
$252B
$1.24M 0.03%
+15,000
New +$1.11M
IVT icon
257
InvenTrust Properties
IVT
$2.6B
$1.23M 0.03%
49,669
-9,706
-16% -$240K
AXSM icon
258
Axsome Therapeutics
AXSM
$10.8B
$1.22M 0.03%
15,118
+6,200
+70% +$459K
SWTX
259
DELISTED
SpringWorks Therapeutics
SWTX
$1.21M 0.03%
32,214
-15,036
-32% -$633K
NVNO
260
enVVeno Medical
NVNO
$6.78M
$1.21M 0.03%
6,594
+128
+2% +$22.3K
LION icon
261
Lionsgate Studios
LION
$3.85B
$1.21M 0.03%
+150,000
New +$1.27M
ITCI
262
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.16M 0.03%
+17,000
New +$1.18M
DYN icon
263
Dyne Therapeutics
DYN
$4.83B
$1.16M 0.03%
32,944
-181
-0.5% -$5.26K
FNA
264
DELISTED
Paragon 28, Inc.
FNA
$1.14M 0.03%
166,743
+47,098
+39% +$398K
EVLV icon
265
Evolv Technologies
EVLV
$1.07B
$1.13M 0.03%
444,123
-362,500
-45% -$1.2M
GLOB icon
266
Globant
GLOB
$1.61B
$1.13M 0.03%
+6,317
New +$1.11M
CRNX icon
267
Crinetics Pharmaceuticals
CRNX
$8.9B
$1.13M 0.03%
25,121
+19,100
+317% +$882K
STNE icon
268
StoneCo
STNE
$2.69B
$1.12M 0.03%
+93,614
New +$1.38M
ANNX icon
269
Annexon
ANNX
$918M
$1.12M 0.03%
228,277
-20,000
-8% -$103K
ALCY
270
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.11M 0.03%
103,486
– –
MRSN
271
DELISTED
Mersana Therapeutics
MRSN
$1.09M 0.03%
21,772
+4,400
+25% +$318K
ALC icon
272
Alcon
ALC
$33.9B
$1.09M 0.03%
12,254
+6,200
+102% +$529K
HYAC
273
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.09M 0.03%
103,486
– –
ATEC icon
274
Alphatec Holdings
ATEC
$1.42B
$1.08M 0.03%
103,771
-19,050
-16% -$222K
CGEM icon
275
Cullinan Oncology
CGEM
$1.16B
$1.08M 0.03%
61,975
+2,623
+4% +$55.9K
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.